Cart
sales@molnova.com
Mitraphylline
CAS No. 509-80-8
Mitraphylline( —— )
Catalog No. M24473 CAS No. 509-80-8
Mitraphylline has antiproliferative effects on human glioma and neuroblastoma cell lines. It also has anti-inflammatory activity, it inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 132 | In Stock |
|
| 5MG | 123 | In Stock |
|
| 10MG | 217 | In Stock |
|
| 25MG | 370 | In Stock |
|
| 50MG | 532 | In Stock |
|
| 100MG | 756 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMitraphylline
-
NoteResearch use only, not for human use.
-
Brief DescriptionMitraphylline has antiproliferative effects on human glioma and neuroblastoma cell lines. It also has anti-inflammatory activity, it inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
-
DescriptionMitraphylline has antiproliferative effects on human glioma and neuroblastoma cell lines. It also has anti-inflammatory activity, it inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorIL Receptor|NF-κB|TNF-α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number509-80-8
-
Formula Weight368.43
-
Molecular FormulaC21H24N2O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:6.76 mg/mL (18.35 mM; Need ultrasonic)
-
SMILESC[C@@H]([C@@H]1[C@@H]2C[C@@H]([C@@](CC3)(c(cccc4)c4N4)C4=O)N3C1)OC=C2C(OC)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Differential alkaloid profile in Uncaria tomentosa micropropagated plantlets and root cultures.Biotechnol Lett. 2013 May;35(5):791-7.
molnova catalog
related products
-
Edasalonexent
Edasalonexent (CAT-1004) is a bifunctional, orally administered small molecule that covalently links 2 compounds known to inhibit NF‐κB, salicylic acid and docosahexaenoic acid (DHA).
-
BML-190
BML-190 is a specific CB2 receptor inverse agonist (Ki: 435 nM), with 50-fold selectivity over CB1 receptor.
-
SEMBL
SEMBL is a potent NF-κB inhibitor that inhibits DNA binding of NF-κB component p65.
